DigestRedComo funciona
Red
/
Empresas
Bi
No verificado

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

34 Comunicados de prensa

Ver todos los comunicados de prensa
02/09/2026
Mercado laboral
Salud
Biotecnología
Ciencia
Farmacéutica
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
02/09/2026
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
29/06/2026
Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
29/06/2026
Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
15/06/2026
Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
15/06/2026
Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
01/04/2026
Mercado laboral
Industria
Ciencia
Fitness
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
01/04/2026
Mercado laboral
Industria
Salud
Técnica
Biotecnología
Fitness
Farmacéutica
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
30/03/2026
Mercado laboral
Industria
Salud
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
30/03/2026
Mercado laboral
Industria
Salud
Biotecnología
Ciencia
Farmacéutica
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0